SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-23-100910
Filing Date
2023-09-14
Accepted
2023-09-14 21:31:06
Documents
1
Period of Report
2023-09-14

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2326121-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2326121-1_3seq1.xml 3 9362
  Complete submission text file 0001104659-23-100910.txt   11957
Mailing Address ONE LETTERMAN DRIVE BUILDING D, SUITE D3-300 SAN FRANCISCO CA 94129
Business Address ONE LETTERMAN DRIVE BUILDING D, SUITE D3-300 SAN FRANCISCO CA 94129 415-489-9980
Redmile Group, LLC (Reporting) CIK: 0001425738 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-41799 | Film No.: 231256516

Mailing Address 45 W. 27TH STREET, FLOOR 11 NEW YORK NY 10001
Business Address
Green Jeremy (Reporting) CIK: 0001650527 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41799 | Film No.: 231256515

Mailing Address LETTERMAN DIGITAL ARTS CENTER ONE LETTERMAN DRIVE, SUITE D3-300 SAN FRANCISCO CA 94129
Business Address LETTERMAN DIGITAL ARTS CENTER ONE LETTERMAN DRIVE, SUITE D3-300 SAN FRANCISCO CA 94129 415-489-9980
Redmile Biopharma Investments II, L.P. (Reporting) CIK: 0001772230 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-41799 | Film No.: 231256514

Mailing Address 5505 MOREHOUSE DRIVE, SUITE 300 SAN DIEGO CA 92121
Business Address 5505 MOREHOUSE DRIVE, SUITE 300 SAN DIEGO CA 92121 (619) 937-2754
RayzeBio, Inc. (Issuer) CIK: 0001825367 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations